SUNESIS PHARMACEUTICALS INC Contracts & Agreements

First Amendment to Lease by and between the Company and Plastino II, LP, dated August 21, 2024 (Filed With SEC on November 13, 2024)

Amended and Restated Outside Director Compensation Policy (Filed With SEC on August 14, 2024)

Employment Agreement by and between the Company and Michael Faerm, dated as of May 11, 2024 (Filed With SEC on May 14, 2024)

Consulting Agreement by and between the Company and Daniel Chevallard, dated March 20, 2024 (Filed With SEC on May 9, 2024)

Employment Agreement by and between the Company and Melody Burcar, dated September 30, 2022, as amended by the Amendment to Employment Agreement by and between the Company and... (Filed With SEC on March 20, 2024)

License Agreement for RAF, dated December 16, 2019, by and between the Registrant and Day One Biopharmaceuticals, Inc (Filed With SEC on March 7, 2024)

Amendment No. 1 to License Agreement for RAF, dated March 4, 2024, by and between the Registrant and Day One Biopharmaceuticals, Inc (Filed With SEC on March 7, 2024)

Amendment No. 1 to Royalty Purchase Agreement, dated March 4, 2024, by and between the Registrant and XOMA (US), LLC (Filed With SEC on March 7, 2024)

Second Amendment to Loan and Security Agreement, dated March 1, 2024, by and between the Registrant and Oxford Finance LLC and First-Citizens Bank & Trust Company (Filed With SEC on March 7, 2024)

First Amendment to Lease by and between the Company and Plastino II, LP, dated August 22, 2023 (Filed With SEC on November 9, 2023)

Executive Engagement Agreement by and between the Company and Darrel P. Cohen, dated August 7, 2023 (Filed With SEC on November 9, 2023)

Amended and Restated Outside Director Compensation Policy (Filed With SEC on August 14, 2023)

Consulting Agreement between the Company and Lisa Rojkjaer, M.D., dated May 5, 2023 (Filed With SEC on May 5, 2023)

First Amendment to Loan and Security Agreement between the Registrant. and Silicon Valley Bank, dated as of August 26, 2022 (Filed With SEC on November 10, 2022)

Executive Employment Agreement by and between the Company and Mark Rothera, dated September 15, 2022 (Filed With SEC on September 19, 2022)

Separation Agreement and Release by and between the Company and Ivor Royston, dated September 15, 2022 (Filed With SEC on September 19, 2022)

2022 Employee Stock Purchase Plan (Filed With SEC on June 8, 2022)

Executive Incentive Compensation Plan (Filed With SEC on March 17, 2022)

Loan and Security Agreement, dated November 4, 2021, by and among Viracta Therapeutics, Inc., Viracta Subsidiary, Inc., Silicon Valley Bank and Oxford Finance LLC (Filed With SEC on November 10, 2021)

Mutual Termination Agreement, by and between Viracta Subsidiary, Inc. and Shenzhen Salubris Pharmaceutical Co. Ltd (Filed With SEC on August 23, 2021)

2021 Inducement Equity Incentive Plan and form of agreement thereunder (Filed With SEC on August 12, 2021)

Amendment to Employment Agreement between Viracta Therapeutics, Inc. and Ivor Royston, M.D., dated August 12, 2021 (Filed With SEC on August 12, 2021)

Amendment to Employment Agreement between Viracta Therapeutics, Inc. and Daniel Chevallard, dated August 12, 2021 (Filed With SEC on August 12, 2021)

Amendment to Employment Agreement between Viracta Therapeutics, Inc. and Lisa Rojkjaer, M.D., dated August 12, 2021 (Filed With SEC on August 12, 2021)

Open Market Sale AgreementSM, dated May 28, 2021, by and between Viracta Therapeutics, Inc. and Jefferies LLC (Filed With SEC on May 28, 2021)

First Amendment to Loan and Security Agreement between Viracta Subsidiary, Inc. and Silicon Valley Bank, dated as of May 27, 2021 (Filed With SEC on May 28, 2021)

Amended and Restated Outside Director Compensation Plan (Filed With SEC on May 13, 2021)

Royalty Purchase Agreement by and between the Registrant and XOMA (US) LLC, dated March 22, 2021 (Filed With SEC on May 13, 2021)

Description of Capital Stock (Filed With SEC on February 24, 2021)

Form of Executive Severance Benefits Agreement between Sunesis Pharmaceuticals, Inc. and certain officers (Filed With SEC on December 22, 2020)

Agreement and Plan of Merger and Reorganization, dated November 29, 2020, by and among Sunesis Pharmaceuticals, Inc., Sol Merger Sub, Inc. and Viracta Therapeutics, Inc (Filed With SEC on November 30, 2020)

Form of Sunesis Pharmaceuticals, Inc. Support Agreement, dated November 29, 2020 (Filed With SEC on November 30, 2020)

Form of Viracta Therapeutics, Inc. Support Agreement, dated November 29, 2020 (Filed With SEC on November 30, 2020)

Form of Lock-Up Agreement, dated November 29, 2020 (Filed With SEC on November 30, 2020)

Form of Retention Benefits Letter between Sunesis Pharmaceuticals, Inc. and certain officers (Filed With SEC on November 30, 2020)

Consulting Agreement, dated May 2, 2020, by and between the Registrant and William P. Quinn (Filed With SEC on August 11, 2020)

Executive Severance Benefits Agreement, dated May 4, 2020, by and between the Registrant and Tina Gullotta (Filed With SEC on August 11, 2020)

Underwriting Agreement relating to the Offering, dated July 29, 2020 (Filed With SEC on July 31, 2020)

Description of Capital Stock (Filed With SEC on May 7, 2020)

Deferral Agreement, dated April 2, 2020, by and between the Registrant and Silicon Valley Bank (Filed With SEC on May 7, 2020)

Amended and Restated License Agreement, dated December 13, 2019, by and between the Registrant and Millennium Pharmaceuticals, Inc (Filed With SEC on March 10, 2020)

Sunesis Pharmaceuticals, Inc. 2020 Bonus Program (Filed With SEC on February 14, 2020)

Underwriting Agreement relating to the Common Stock Offering, dated July 10, 2019 (Filed With SEC on July 12, 2019)

Underwriting Agreement relating to the Series F Offering, dated July 10, 2019 (Filed With SEC on July 12, 2019)

Form of Specimen Series F Preferred Stock Certificate (Filed With SEC on July 12, 2019)

Term Loan Agreement, dated April 26, 2019, by and between Sunesis Pharmaceuticals, Inc. and Silicon Valley Bank (Filed With SEC on April 29, 2019)

Second Amended and Restated Collaboration Agreement, dated December 16, 2013, by and between the Registrant and Biogen MA Inc (Filed With SEC on March 7, 2019)

Sunesis Pharmaceuticals, Inc. 2019 Bonus Program (Filed With SEC on February 4, 2019)

Underwriting Agreement relating to the Common Stock Offering, dated January 17, 2019 (Filed With SEC on January 22, 2019)

Underwriting Agreement relating to the Series E Offering, dated January 17, 2019 (Filed With SEC on January 22, 2019)

Form of Specimen Series E Preferred Stock Certificate (Filed With SEC on January 22, 2019)

Registration Rights Agreement, dated as of June 25, 2018, by and between Sunesis Pharmaceuticals, Inc. and Aspire Capital Fund, LLC (Filed With SEC on June 25, 2018)

Common Stock Purchase Agreement, dated as of June 25, 2018, by and between Sunesis Pharmaceuticals, Inc. and Aspire Capital Fund, LLC (Filed With SEC on June 25, 2018)

Fifth Amendment to Office Lease, dated October 17, 2017, by and between the Registrant and Kashiwa Fudosan America, Inc., for office space located at 395 Oyster Point Boulevard,... (Filed With SEC on March 9, 2018)

Partial Lease Termination Agreement to Office Lease, dated November 19, 2017, by and between the Registrant and Kashiwa Fudosan America, Inc., for office space located at 395... (Filed With SEC on March 9, 2018)

Advisory Service Agreement, by and between Sunesis Pharmaceuticals, Inc. and Daniel N. Swisher, Jr. dated as of December 21, 2017 (Filed With SEC on March 9, 2018)

Executive Severance Benefits Agreement, dated November 30, 2017, by and between the Registrant and William P. Quinn (Filed With SEC on March 9, 2018)

Sunesis Pharmaceuticals, Inc. 2018 Bonus Program (Filed With SEC on February 5, 2018)

Amendment No. 3 to Sales Agreement, dated November 7, 2017, between Sunesis Pharmaceuticals, Inc. and Cantor Fitzgerald & Co (Filed With SEC on November 7, 2017)

Second Amendment to Loan and Security Agreement (Filed With SEC on November 2, 2017)

Underwriting Agreement relating to the Common Stock Offering, dated October 25, 2017 (Filed With SEC on October 26, 2017)

Underwriting Agreement relating to the Series D Offering, dated October 25, 2017 (Filed With SEC on October 26, 2017)

Form of Specimen Series D Preferred Stock Certificate (Filed With SEC on October 26, 2017)

Form of Common Stock Purchase Warrant (Filed With SEC on October 26, 2017)

Transition and Resignation Agreement, by and between Sunesis Pharmaceuticals, Inc. and Eric Bjerkholt, dated as of April 21, 2017 (Filed With SEC on July 27, 2017)

FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on June 30, 2017)

SUNESIS PHARMACEUTICALS, INC. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY (Filed With SEC on May 8, 2017)

SUNESIS PHARMACEUTICALS, INC. 2017 BONUS PROGRAM (Filed With SEC on March 27, 2017)

4,935,500 Shares SUNESIS PHARMACEUTICALS, INC. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on October 19, 2016)

1,558 Shares SUNESISPHARMACEUTICALS, INC. Series C Convertible Preferred Stock UNDERWRITING AGREEMENT (Filed With SEC on October 19, 2016)

SUNESIS PHARMACEUTICALS, INC. A Delaware Corporation (Filed With SEC on October 19, 2016)

Non-Employee Director Compensation Information (Filed With SEC on July 29, 2016)

O Y S T E RP O I N TM A R I N AP L A Z A Fourth Amendment to Office Lease (Filed With SEC on July 29, 2016)

Non-Employee Director Compensation Information (Filed With SEC on May 9, 2016)

LOAN AND SECURITY AGREEMENT (Filed With SEC on May 9, 2016)

WARRANT TO PURCHASE STOCK (Filed With SEC on May 9, 2016)

THIRD AMENDED AND RESTATED EXECUTIVE SEVERANCE BENEFITS AGREEMENT (Filed With SEC on May 9, 2016)

SUNESIS PHARMACEUTICALS, INC. 2016 BONUS PROGRAM (Filed With SEC on March 28, 2016)

9,561,905 Shares SUNESIS PHARMACEUTICALS, INC. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on December 16, 2015)

20,200 Shares SUNESISPHARMACEUTICALS, INC. Series B Convertible Preferred Stock UNDERWRITING AGREEMENT (Filed With SEC on December 16, 2015)

SUNESIS PHARMACEUTICALS, INC. A Delaware Corporation (Filed With SEC on December 16, 2015)

OYSTER POINT MARINA PLAZA Third Amendment to Office Lease (Filed With SEC on November 5, 2015)

SUNESIS PHARMACEUTICALS, INC. 2015 BONUS PROGRAM (Filed With SEC on March 23, 2015)

OYSTER POINT MARINA PLAZA Second Amendment to Office Lease (Filed With SEC on March 12, 2015)

SUNESIS PHARMACEUTICALS, INC. CONTROLLED EQUITY OFFERINGSM AMENDMENT NO. 2 TO SALES AGREEMENT (Filed With SEC on March 12, 2015)

THIRD AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on March 2, 2015)

OYSTER POINT MARINA PLAZA First Amendment to Office Lease (Filed With SEC on August 5, 2014)

SUNESIS PHARMACEUTICALS, INC. 2014 BONUS PROGRAM (Filed With SEC on March 24, 2014)

EXECUTIVE SEVERANCE BENEFITS AGREEMENT (Filed With SEC on March 6, 2014)

SECONDAMENDED AND RESTATED COLLABORATION AGREEMENT (Filed With SEC on March 6, 2014)

AMENDED AND RESTATED LICENSE AGREEMENT (Filed With SEC on March 6, 2014)

O Y S T E R P O I N T M A R I N A P L A Z A Office Lease of SUITE 400 to SUNESIS PHARMACEUTICALS, INC., a Delaware corporation 395Oyster Point Boulevard South San Francisco, CA... (Filed With SEC on March 6, 2014)

SECOND AMENDMENT TO SUBLEASE (Filed With SEC on March 6, 2014)

4,650,000 Shares Series A Warrants to Purchase 4,650,000 Shares Series B Warrants to Purchase 4,650,000 Shares SUNESIS PHARMACEUTICALS, INC. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on February 27, 2014)

COMMON STOCK PURCHASE WARRANT SERIES A CUSIP ###-###-#### SUNESIS PHARMACEUTICALS, INC. (Filed With SEC on February 27, 2014)

COMMON STOCK PURCHASE WARRANT SERIES B CUSIP ###-###-#### SUNESIS PHARMACEUTICALS, INC. (Filed With SEC on February 27, 2014)

WARRANT AGENCY AGREEMENT (Filed With SEC on February 27, 2014)

SECOND AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on November 12, 2013)

Non-Employee Director Compensation Information (Filed With SEC on August 2, 2013)

TERMINATION AND REGISTRATION RIGHTS AGREEMENT (Filed With SEC on June 11, 2013)

SUNESIS PHARMACEUTICALS, INC. CONTROLLED EQUITYOFFERINGSM AMENDMENT NO. 1 TO SALES AGREEMENT (Filed With SEC on April 10, 2013)

SUNESIS PHARMACEUTICALS, INC. 2013 BONUS PROGRAM (Filed With SEC on March 27, 2013)

FIRST AMENDMENT OF SUBLEASE (Filed With SEC on March 13, 2013)

SUNESIS PHARMACEUTICALS, INC. AMENDMENT TO EXECUTIVE SEVERANCE BENEFITS AGREEMENT (Filed With SEC on March 13, 2013)

REVENUE PARTICIPATION AGREEMENT BY AND BETWEEN SUNESIS PHARMACEUTICALS,INC. AND RPI FINANCE TRUST DATED AS OF MARCH 29, 2012 (Filed With SEC on May 15, 2012)

FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on May 15, 2012)

Exhibit A Form of Warrant (Filed With SEC on May 15, 2012)

SUNESIS PHARMACEUTICALS, INC. 2012 BONUS PROGRAM (Filed With SEC on March 28, 2012)

Exhibit A Executive Severance Benefits Agreement Exhibit B Indemnification Agreement (Filed With SEC on March 14, 2012)

EXECUTIVE SEVERANCE BENEFITS AGREEMENT (Filed With SEC on March 14, 2012)

SUNESIS PHARMACEUTICALS, INC. STOCK OPTION GRANT NOTICE (2011 EQUITY INCENTIVE PLAN) (Filed With SEC on March 14, 2012)

SUNESIS PHARMACEUTICALS, INC. RESTRICTED STOCK UNIT GRANT NOTICE 2011 EQUITY INCENTIVE PLAN (Filed With SEC on March 14, 2012)

FIFTH AGREEMENT REGARDING PRIVATE PLACEMENT OF SECURITIES OF SUNESIS PHARMACEUTICALS, INC. (Filed With SEC on February 3, 2012)

LOAN AND SECURITY AGREEMENT (Filed With SEC on October 19, 2011)

WARRANT TO PURCHASE STOCK (Filed With SEC on October 19, 2011)

SUNESIS PHARMACEUTICALS, INC. $20,000,000 of Common Stock (par value $0.0001 per share) Controlled Equity OfferingSM Sales Agreement (Filed With SEC on August 11, 2011)

MASTER SERVICES AGREEMENT (Filed With SEC on May 12, 2011)

FIRST AMENDMENT TO MASTER SERVICES AGREEMENT (Filed With SEC on May 12, 2011)

AMENDED AND RESTATED COLLABORATION AGREEMENT (Filed With SEC on May 12, 2011)

LICENSE AGREEMENT (Filed With SEC on May 12, 2011)

TERMINATION AND TRANSITION AGREEMENT (Filed With SEC on May 12, 2011)

SUNESIS PHARMACEUTICALS, INC. (Filed With SEC on March 29, 2011)

MASTER SERVICES AGREEMENT (Filed With SEC on March 29, 2011)

FIRST AMENDMENT TO THE MASTER SERVICES AGREEMENT (Filed With SEC on March 29, 2011)

SECOND AMENDMENT TO THE MASTER SERVICES AGREEMENT (Filed With SEC on March 29, 2011)

THIRD AMENDMENT TO THE MASTER SERVICES AGREEMENT (Filed With SEC on March 29, 2011)

MASTER SERVICES AGREEMENT (Filed With SEC on March 29, 2011)

MASTER SERVICES AGREEMENT (MSA) (Filed With SEC on March 29, 2011)

SUNESIS PHARMACEUTICALS, INC. 2011 BONUS PROGRAM (Filed With SEC on February 18, 2011)

THIRD AGREEMENT REGARDING PRIVATE PLACEMENT OF SECURITIES OF SUNESIS PHARMACEUTICALS, INC. (Filed With SEC on January 21, 2010)

SUNESIS PHARMACEUTICALS, INC. $15,000,000 OfCommon Stock (par value $0.0001 per share) (Filed With SEC on January 21, 2010)

SECOND AGREEMENT REGARDING PRIVATE PLACEMENT OF SECURITIES OF SUNESIS PHARMACEUTICALS, INC. (Filed With SEC on November 2, 2009)

SUNESIS PHARMACEUTICALS, INC. CHANGE OF CONTROL PAYMENT PLAN (Filed With SEC on July 28, 2009)

SUNESIS PHARMACEUTICALS, INC. 2009 BONUS PROGRAM (Filed With SEC on July 28, 2009)

AGREEMENT REGARDING PRIVATE PLACEMENT OF SECURITIES OF (Filed With SEC on July 2, 2009)

AMENDEDAND RESTATED EXECUTIVESEVERANCE BENEFITS AGREEMENT (Filed With SEC on April 3, 2009)

SECONDAMENDED AND RESTATED EXECUTIVESEVERANCE BENEFITS AGREEMENT (Filed With SEC on April 3, 2009)

Summaryof Non-Employee Director Cash Compensation Arrangements (Filed With SEC on April 3, 2009)

INVESTORRIGHTS AGREEMENT (Filed With SEC on April 3, 2009)

INTELLECTUALPROPERTY ASSIGNMENT AND LICENSETERMINATION AGREEMENT (Filed With SEC on March 10, 2009)

Exhibit10.43 SUNESISPHARMACEUTICALS, INC. 2006EMPLOYMENT COMMENCEMENT INCENTIVE PLAN ADOPTEDBY THE BOARD OF DIRECTORS ON NOVEMBER 29, 2005 EFFECTIVEAS OF JANUARY 1, 2006... (Filed With SEC on December 23, 2008)

Exhibit10.71 SUNESISPHARMACEUTICALS, INC. 2006EMPLOYMENT COMMENCEMENT INCENTIVE PLAN STOCKOPTION GRANT NOTICE AND STOCK OPTION AGREEMENT (Filed With SEC on December 23, 2008)

SUNESIS PHARMACEUTICALS, INC. CONSULTING AGREEMENT Effective Date:August 5, 2008 Expiration Date:August 31, 2009 Contract No. 2008-3101.0 (Filed With SEC on November 7, 2008)

SUNESIS PHARMACEUTICALS, INC. 2005 EQUITY INCENTIVE AWARD PLAN STOCK OPTION GRANT NOTICE AND STOCK OPTION AGREEMENT (OUTSIDE DIRECTORS - ANNUAL GRANT) (Filed With SEC on November 7, 2008)

SUNESIS PHARMACEUTICALS, INC. 2008 Executive Bonus Program (Filed With SEC on August 7, 2008)

SUNESIS PHARMACEUTICALS, INC. STOCK OPTION GRANT NOTICE AND STOCK OPTION AGREEMENT UNDER THE 2006 EMPLOYMENT COMMENCEMENT INCENTIVE PLAN (Filed With SEC on August 7, 2008)

EXECUTIVE SEVERANCE BENEFITS AGREEMENT (Filed With SEC on August 7, 2008)

AMENDED AND RESTATED EXECUTIVE SEVERANCE BENEFITS AGREEMENT (Filed With SEC on August 7, 2008)

AMENDED AND RESTATEDEXECUTIVE SEVERANCE BENEFITS AGREEMENT (Filed With SEC on August 7, 2008)

AMENDED AND RESTATED EXECUTIVE SEVERANCE BENEFITS AGREEMENT (Filed With SEC on August 7, 2008)

RELEASE AGREEMENT (Filed With SEC on August 7, 2008)

Acceptance of Option Amendment (Filed With SEC on August 7, 2008)

SUNESIS PHARMACEUTICALS, INC. 2008 Bonus Program (Filed With SEC on March 11, 2008)

SUNESIS PHARMACEUTICALS, INC. 2006 EMPLOYMENT COMMENCEMENT INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS ON NOVEMBER 29, 2005 EFFECTIVE AS OF JANUARY 1, 2006 (AMENDED AND... (Filed With SEC on December 11, 2007)

SUNESIS PHARMACEUTICALS, INC. Code of Business Conduct & Ethics (Filed With SEC on December 11, 2007)

SUNESIS PHARMACEUTICALS, INC. 2005 EQUITY INCENTIVE AWARD PLAN STOCK OPTION GRANT NOTICE AND STOCK OPTION AGREEMENT (Filed With SEC on September 19, 2007)

SUNESIS PHARMACEUTICALS, INC. 2005 EQUITY INCENTIVE AWARD PLAN (Amended and Restated June 27, 2007) ARTICLE 1 PURPOSE (Filed With SEC on August 8, 2007)

4,750,000 Shares SUNESIS PHARMACEUTICALS, INC. Common Stock, $0.0001 par value per share UNDERWRITING AGREEMENT (Filed With SEC on May 24, 2007)

AMENDMENT TO THE AMENDED AND RESTATED CONSULTING AGREEMENT (Filed With SEC on May 9, 2007)

SUNESIS PHARMACEUTICALS, INC. CONFIDENTIAL INFORMATION AND INVENTION ASSIGNMENT AGREEMENT (Filed With SEC on May 9, 2007)

SUNESIS PHARMACEUTICALS, INC. 2005 EQUITY INCENTIVE AWARD PLAN (Amended and Restated September 13, 2006) ARTICLE 1 PURPOSE (Filed With SEC on November 9, 2006)

SUNESIS PHARMACEUTICALS, INC. EMPLOYEE STOCK PURCHASE PLAN (Amended and Restated on September 13, 2006) (Filed With SEC on November 9, 2006)

SUNESIS PHARMACEUTICALS, INC. 2006 EMPLOYMENT COMMENCEMENT INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS ON NOVEMBER 29, 2005 EFFECTIVE AS OF JANUARY 1, 2006 (AMENDED AND... (Filed With SEC on November 9, 2006)

COMMONSTOCK AND WARRANT PURCHASE AGREEMENT (Filed With SEC on March 22, 2006)

REGISTRATIONRIGHTS AGREEMENT (Filed With SEC on March 22, 2006)

WARRANT TO PURCHASE SHARES OF COMMON STOCK OF SUNESIS PHARMACEUTICALS, INC. (Filed With SEC on March 22, 2006)

Shares SUNESIS PHARMACEUTICALS, INC. Common Stock $0.0001 Par Value (Filed With SEC on September 27, 2005)

SUNESISPHARMACEUTICALS, INC. 2005EQUITY INCENTIVE AWARD PLAN ARTICLE 1 PURPOSE (Filed With SEC on September 27, 2005)

SUNESIS PHARMACEUTICALS, INC. EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on September 27, 2005)

SUNESIS PHARMACEUTICALSINCORPORATED 1998 STOCK PLAN (amended as of October 4, 2001) (Filed With SEC on December 23, 2004)

SUNESIS PHARMACEUTICALS, INC. 2001 STOCK PLAN (Filed With SEC on December 23, 2004)

SUNESISPHARMACEUTICALS, INC. INDEMNIFICATIONAGREEMENT (Filed With SEC on December 23, 2004)

Modified Employment Agreement April 15, 2003 (Filed With SEC on December 23, 2004)

FirstAmendment to Employment Agreement dated December 1, 2003 (Filed With SEC on December 23, 2004)

PROMISSORYNOTE (Filed With SEC on December 23, 2004)

PROMISSORY NOTE (Filed With SEC on December 23, 2004)

EIGHTH AMENDEDAND RESTATED INVESTORRIGHTS AGREEMENT (Filed With SEC on December 23, 2004)

MOSAIC PHARMACEUTICALS, INC. Common Stock Purchase Warrant (Filed With SEC on December 23, 2004)

STOCK PURCHASE WARRANT (Filed With SEC on December 23, 2004)

WARRANT TOPURCHASE 3,000 SHARES OF SERIES C-1 PREFERRED STOCK (Filed With SEC on December 23, 2004)

EXHIBIT A DESCRIPTION OF PREMISES (Filed With SEC on December 23, 2004)

MASTER SECURITY AGREEMENT dated as of June 15, 2000 (Agreement) (Filed With SEC on December 23, 2004)

Category

Industry

Companies

Contracts

SUNESIS PHARMACEUTICALS INC Contracts & Agreements